P

Inventor

MORTON DONALD L

US13 patents
⚠️ This page may combine multiple inventors who share the name “MORTON DONALD L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

(unassigned)

4 patents
US5993828ANov 30, 1999

Tumor associated antigen compositions and methods

37 citations91
US5882654AMar 16, 1999

Polyvalent melanoma vaccine

18 citations82
US5840317ANov 24, 1998

Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen

8 citations72
US5700649ADec 23, 1997

Method of detection of urinary tumor associated antigen

17 citations72

WAYNE JOHN CANCER INST

3 patents
US6218166B1Apr 17, 2001

Adjuvant incorporation into antigen carrying cells: compositions and methods

WAYNE JOHN CANCER INST113 citations94
US6815170B1Nov 9, 2004

Methods for lymph node identification

WAYNE JOHN CANCER INST23 citations91
US6168787B1Jan 2, 2001

Pluripotent vaccine against enveloped viruses

WAYNE JOHN CANCER INST8 citations72

CANCERVAX CORP

2 patents
US6491926B1Dec 10, 2002

35 kD tumor associated protein antigen: uses and methods of detection

CANCERVAX CORP12 citations70
US7097846B2Aug 29, 2006

35 kD tumor associated protein antigen: uses and methods of detection

CANCERVAX CORP0 citations40

DECATUR FRP PARTNERS

2 patents
US5102867AApr 7, 1992

Therapeutic treatment of abnormal cell growth with follicle regulatory protein

DECATUR FRP PARTNERS2 citations57
US4849402AJul 18, 1989

Therapeutic treatment of abnormal cell growth with follicle regulatory protein

DECATUR FRP PARTNERS0 citations47

UNIV CALIFORNIA

1 patent
US4557931ADec 10, 1985

Antigenic compositions and methods for using same

UNIV CALIFORNIA42 citations87

MORTON DONALD L

1 patent
US8557257B2Oct 15, 2013

Mycobacterial immunotherapy for cancer treatment

MORTON DONALD L3 citations56